Medication info
Twinact Tablet 40/5 mg

Twinact Tablet 40/5 mg

Prescription medicationOral
Ingredient · strength
Telmisartan Powder 23.9%›167.36mg / 1 tabletAmlodipine Besylate›6.935mg / 1 tablet
Manufacturer / importer
Dasan Pharmaceutical Co., Ltd.
Appearance
A white and light gray double tablet that is bilaterally convex and oval-shaped.
Packaging
30 tablets (10 tablets/PTP x 3)
Approval status
Active

MFDS item code 201605707 · Approved 2016.09.29 · Insurance code 678600700

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. It is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan) before administering this drug; however, a direct switch to this drug may be considered if blood pressure is not controlled with the individual components as follows. - 40/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this drug 40/5 milligrams. - 40/10 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. In patients taking telmisartan and amlodipine in combination, they may switch to this drug (a fixed-dose combination with the same amount of each active ingredient) for convenience (limited to this drug 40/5 milligrams). ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment; however, it is recommended that treatment be initiated at a low dose in patients with severe renal impairment, with gradual dose increases. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine dosage is recommended for older adults, but caution should be exercised when increasing the dose. (See section ‘3. Patients requiring caution in administration’.) In older adults aged 75 years and older, amlodipine clearance is reduced; therefore, treatment should be initiated at a low dose and the dose increased gradually.
Child dose
Aged 18 years or younger: Administration of this drug is not recommended because safety and efficacy have not been established.

Ingredients

Manufacturer
Dasan Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication is used to effectively control blood pressure in patients with essential hypertension whose blood pressure is not adequately controlled by monotherapy with amlodipine or telmisartan.

How to take

Adult dose

The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. It is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan) before administering this drug; however, a direct switch to this drug may be considered if blood pressure is not controlled with the individual components as follows. - 40/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this drug 40/5 milligrams. - 40/10 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. In patients taking telmisartan and amlodipine in combination, they may switch to this drug (a fixed-dose combination with the same amount of each active ingredient) for convenience (limited to this drug 40/5 milligrams). ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment; however, it is recommended that treatment be initiated at a low dose in patients with severe renal impairment, with gradual dose increases. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine dosage is recommended for older adults, but caution should be exercised when increasing the dose. (See section ‘3. Patients requiring caution in administration’.) In older adults aged 75 years and older, amlodipine clearance is reduced; therefore, treatment should be initiated at a low dose and the dose increased gradually.

Child dose

Aged 18 years or younger: Administration of this drug is not recommended because safety and efficacy have not been established.

Precautions

This medication can pose a serious risk to the fetus, especially during the second and third trimesters, so it should not be taken by women who are pregnant or may become pregnant. It should not be used by individuals who have allergies to the active ingredients or similar compounds, those with severe liver or heart issues, pregnant or breastfeeding women, and patients with certain kidney diseases. Patients with primary aldosteronism, valvular heart disease, poor liver function, gastrointestinal diseases, renal vascular problems, those on dialysis, and the elderly should use this medication with special caution. This medication may commonly cause dizziness or swelling in the limbs, and rarely, severe reactions or allergies, such as hypotension and liver function abnormalities, may occur; if any unusual symptoms arise, medical consultation should be sought immediately. This medication should not be used during pregnancy, and if pregnancy is confirmed, it should be discontinued as soon as possible and switched to another safe treatment method. Since this medication has blood pressure-lowering effects, patients with excessively low blood pressure or dehydration should consult a doctor before taking this medication, and blood pressure and kidney function should be monitored regularly during the course of treatment. Additionally, potassium levels may rise, so caution is required when taking it alongside potassium-rich foods, potassium supplements, or certain diuretics. This medication may interact with other drugs, so patients must inform their doctor or pharmacist, especially when taking heart medications, diuretics, lithium, warfarin, or non-steroidal anti-inflammatory drugs. Dizziness or drowsiness may occur when driving or operating machinery, so caution is urged. In cases of overdose, severe hypotension or heart problems may occur, and immediate medical attention is required, as this medication is not removed by dialysis, necessitating specialized treatment. When storing, keep it out of reach of children, store in a tightly sealed container, and do not transfer to another container.

Side effects

  • Dizziness
  • peripheral edema
  • fainting
  • upper respiratory tract infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 103 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • mood changes
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • sensory disturbances
  • sensory loss
  • taste disturbances
  • tremors
  • extrapyramidal disorder
  • muscle rigidity
  • visual impairment
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • vasculitis
  • cough
  • dyspnea
  • rhinitis
  • changes in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • indigestion
  • nausea
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver dysfunction
  • liver impairment
  • hepatitis
  • jaundice
  • increased liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • hair loss
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug rash
  • urticaria
  • polymorphous exanthema
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • renal dysfunction
  • urinary disorders
  • increased urination
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • increased liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • increased blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin
  • intestinal vascular edema
  • interstitial lung disease
  • interstitial pneumonia
  • eosinophilic pneumonia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a container that blocks light. Additionally, it is advisable to store it at a cool room temperature, i.e., between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

A white and light gray double tablet that is bilaterally convex and oval-shaped.

Package unit

30 tablets (10 tablets/PTP x 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.